BIOMAT Database Logo BIOMAT Database Logo

Risk of tumor recurrence and growth hormone therapy. 1995

M F Rivas-Crespo, and A Gutiérrez-Puebla, and M J Antuña-García, and M Crespo-Hernández

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D009303 Nasopharyngeal Neoplasms Tumors or cancer of the NASOPHARYNX. Cancer of Nasopharynx,Nasopharyngeal Cancer,Cancer of the Nasopharynx,Nasopharynx Cancer,Nasopharynx Neoplasms,Neoplasms, Nasopharyngeal,Cancer, Nasopharyngeal,Cancer, Nasopharynx,Cancers, Nasopharyngeal,Cancers, Nasopharynx,Nasopharyngeal Cancers,Nasopharyngeal Neoplasm,Nasopharynx Cancers,Nasopharynx Neoplasm,Neoplasm, Nasopharyngeal,Neoplasm, Nasopharynx,Neoplasms, Nasopharynx
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005266 Femoral Neoplasms New abnormal growth of tissue in the FEMUR. Femoral Neoplasm,Neoplasm, Femoral,Neoplasms, Femoral
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012509 Sarcoma A connective tissue neoplasm formed by proliferation of mesodermal cells; it is usually highly malignant. Sarcoma, Epithelioid,Sarcoma, Soft Tissue,Sarcoma, Spindle Cell,Epithelioid Sarcoma,Epithelioid Sarcomas,Sarcomas,Sarcomas, Epithelioid,Sarcomas, Soft Tissue,Sarcomas, Spindle Cell,Soft Tissue Sarcoma,Soft Tissue Sarcomas,Spindle Cell Sarcoma,Spindle Cell Sarcomas

Related Publications

M F Rivas-Crespo, and A Gutiérrez-Puebla, and M J Antuña-García, and M Crespo-Hernández
Growth hormone therapy and the risk of tumor recurrence after brain tumor treatment in children.
September 2010, Journal of pediatric endocrinology & metabolism : JPEM,
M F Rivas-Crespo, and A Gutiérrez-Puebla, and M J Antuña-García, and M Crespo-Hernández
Craniopharyngioma recurrence and growth hormone therapy.
March 1988, Lancet (London, England),
M F Rivas-Crespo, and A Gutiérrez-Puebla, and M J Antuña-García, and M Crespo-Hernández
Growth hormone treatment of children with brain tumors and risk of tumor recurrence.
December 2000, The Journal of clinical endocrinology and metabolism,
M F Rivas-Crespo, and A Gutiérrez-Puebla, and M J Antuña-García, and M Crespo-Hernández
Replacement therapy with growth hormone and pituitary tumor recurrence: the relevance of the problem.
September 2008, Journal of endocrinological investigation,
M F Rivas-Crespo, and A Gutiérrez-Puebla, and M J Antuña-García, and M Crespo-Hernández
Growth hormone therapy and tumor recurrence. Findings in children with brain neoplasms and hypopituitarism.
April 1985, American journal of diseases of children (1960),
M F Rivas-Crespo, and A Gutiérrez-Puebla, and M J Antuña-García, and M Crespo-Hernández
Growth hormone therapy and risk of recurrence/progression in intracranial tumors: a meta-analysis.
October 2015, Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology,
M F Rivas-Crespo, and A Gutiérrez-Puebla, and M J Antuña-García, and M Crespo-Hernández
Growth Hormone Therapy Does Not Increase the Risk of Craniopharyngioma and Nonfunctioning Pituitary Adenoma Recurrence.
May 2020, The Journal of clinical endocrinology and metabolism,
M F Rivas-Crespo, and A Gutiérrez-Puebla, and M J Antuña-García, and M Crespo-Hernández
Is brain tumor recurrence increased following growth hormone treatment?
August 1995, Trends in endocrinology and metabolism: TEM,
M F Rivas-Crespo, and A Gutiérrez-Puebla, and M J Antuña-García, and M Crespo-Hernández
Long-term risk of gastrointestinal tumor recurrence after postoperative treatment with recombinant human growth hormone.
January 2000, JPEN. Journal of parenteral and enteral nutrition,
M F Rivas-Crespo, and A Gutiérrez-Puebla, and M J Antuña-García, and M Crespo-Hernández
Growth hormone and tumour recurrence.
June 1992, BMJ (Clinical research ed.),
Copied contents to your clipboard!